EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
3.13.2.1 | adenosine | prevents inhibition by (Z)-9-(5-deoxy-5-fluoro-beta-D-erythro-pent-4-enofuranosyl)adenine | Mus musculus |
EC Number | Application | Comment | Organism |
---|---|---|---|
3.13.2.1 | medicine | antiviral drug design | Mus musculus |
3.13.2.1 | medicine | antiviral drug design | Rattus norvegicus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.13.2.1 | (E)-4',5'-didehydro-2',5'-dideoxy-5'-fluoroadenosine | - |
Rattus norvegicus | |
3.13.2.1 | (E)-4',5'-didehydro-5'-deoxy-5'-chloro-5'-fluoroadenosine | competitive | Rattus norvegicus | |
3.13.2.1 | (E)-9-(5-deoxy-5-fluoro-beta-D-erythro-pent-4-enofuranosyl)adenine | - |
Mus musculus | |
3.13.2.1 | (E)-9-(5-deoxy-5-fluoro-beta-D-erythro-pent-4-enofuranosyl)adenine | - |
Rattus norvegicus | |
3.13.2.1 | (E)-9-(5-deoxy-5-fluoro-beta-D-threo-pent-4-enofuranosyl)-9H-purin-6-amine | competitive | Rattus norvegicus | |
3.13.2.1 | (Z)-4',5'-didehydro-2',5'-dideoxy-5'-fluoroadenosine | competitive | Rattus norvegicus | |
3.13.2.1 | (Z)-4',5'-didehydro-5'-chloro-5'-deoxyadenosine | competitive | Rattus norvegicus | |
3.13.2.1 | (Z)-4',5'-didehydro-5'-deoxy-5'-chloro-5'-fluoroadenosine | competitive | Rattus norvegicus | |
3.13.2.1 | (Z)-9-(5-deoxy-5-fluoro-beta-D-erythro-pent-4-enofuranosyl)adenine | - |
Mus musculus | |
3.13.2.1 | (Z)-9-(5-deoxy-5-fluoro-beta-D-erythro-pent-4-enofuranosyl)adenine | - |
Rattus norvegicus | |
3.13.2.1 | (Z)-9-(5-deoxy-5-fluoro-beta-D-threo-pent-4-enofuranosyl)-9H-purin-6-amine | competitive | Rattus norvegicus | |
3.13.2.1 | 5'-deoxy-5',5'-difluoradenosine | - |
Mus musculus | |
3.13.2.1 | 5'-deoxy-5',5'-difluoradenosine | - |
Rattus norvegicus |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.13.2.1 | S-adenosyl-L-homocysteine + H2O | Mus musculus | - |
adenosine + L-homocysteine | - |
r | |
3.13.2.1 | S-adenosyl-L-homocysteine + H2O | Rattus norvegicus | - |
adenosine + L-homocysteine | - |
r |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.13.2.1 | Mus musculus | - |
- |
- |
3.13.2.1 | Rattus norvegicus | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
3.13.2.1 | - |
Rattus norvegicus |
3.13.2.1 | partial | Mus musculus |
EC Number | Reaction | Comment | Organism | Reaction ID |
---|---|---|---|---|
3.13.2.1 | S-adenosyl-L-homocysteine + H2O = L-homocysteine + adenosine | reaction equilibrium is in vitro strongly in direction of synthesis of S-adenosyl-L-homocysteine | Mus musculus | |
3.13.2.1 | S-adenosyl-L-homocysteine + H2O = L-homocysteine + adenosine | reaction equilibrium is in vitro strongly in direction of synthesis of S-adenosyl-L-homocysteine | Rattus norvegicus |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.13.2.1 | liver | - |
Mus musculus | - |
3.13.2.1 | liver | - |
Rattus norvegicus | - |
EC Number | Storage Stability | Organism |
---|---|---|
3.13.2.1 | -70°C | Mus musculus |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.13.2.1 | DL-homocysteine + adenosine | - |
Mus musculus | S-adenosyl-DL-homocysteine | - |
r | |
3.13.2.1 | DL-homocysteine + adenosine | - |
Rattus norvegicus | S-adenosyl-DL-homocysteine | - |
r | |
3.13.2.1 | S-adenosyl-L-homocysteine + H2O | - |
Mus musculus | adenosine + L-homocysteine | - |
r | |
3.13.2.1 | S-adenosyl-L-homocysteine + H2O | - |
Rattus norvegicus | adenosine + L-homocysteine | - |
r |